Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.

The extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stab...

Full description

Bibliographic Details
Main Authors: Ahmed, A, Wang, X, Lu, Z, Goldsmith, J, Le, X, Grandjean, G, Bartholomeusz, G, Broom, B, Bast, R
Format: Journal article
Language:English
Published: 2011
_version_ 1797085471731351552
author Ahmed, A
Wang, X
Lu, Z
Goldsmith, J
Le, X
Grandjean, G
Bartholomeusz, G
Broom, B
Bast, R
author_facet Ahmed, A
Wang, X
Lu, Z
Goldsmith, J
Le, X
Grandjean, G
Bartholomeusz, G
Broom, B
Bast, R
author_sort Ahmed, A
collection OXFORD
description The extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stability before exposure to paclitaxel may increase its ability to stabilize microtubules and thereby enhance its cytotoxicity. Toward this end, we carried out an siRNA screen to evaluate how genetic depletion affected microtubule stabilization, cell viability, and apoptosis. High content microscopic analysis was carried out in the absence or presence of paclitaxel. Kinase knockdowns that stabilized microtubules strongly enhanced the effects of paclitaxel treatment. Conversely, kinase knockdowns that enhanced paclitaxel-mediated cytotoxicity sensitized cells to microtubule stabilization by paclitaxel. The siRNA screen identified several genes that have not been linked previously to microtubule regulation or paclitaxel response. Gene shaving and Bayesian resampling used to classify these genes suggested three pathways of paclitaxel-induced cell death related to apoptosis and microtubule stability, apoptosis alone, or neither process. Our results offer a functional classification of the genetic basis for paclitaxel sensitivity and they support the hypothesis that stabilizing microtubules prior to therapy could enhance antitumor responses to paclitaxel treatment.
first_indexed 2024-03-07T02:09:19Z
format Journal article
id oxford-uuid:a010dee2-a469-46bf-9718-8360d96ae3b1
institution University of Oxford
language English
last_indexed 2024-03-07T02:09:19Z
publishDate 2011
record_format dspace
spelling oxford-uuid:a010dee2-a469-46bf-9718-8360d96ae3b12022-03-27T02:02:42ZModulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a010dee2-a469-46bf-9718-8360d96ae3b1EnglishSymplectic Elements at Oxford2011Ahmed, AWang, XLu, ZGoldsmith, JLe, XGrandjean, GBartholomeusz, GBroom, BBast, RThe extracellular matrix protein TGFBI enhances the cytotoxic response of cancer cells to paclitaxel by affecting integrin signals that stabilize microtubules. Extending the implications of this knowledge, we tested the more general hypothesis that cancer cell signals which increase microtubule stability before exposure to paclitaxel may increase its ability to stabilize microtubules and thereby enhance its cytotoxicity. Toward this end, we carried out an siRNA screen to evaluate how genetic depletion affected microtubule stabilization, cell viability, and apoptosis. High content microscopic analysis was carried out in the absence or presence of paclitaxel. Kinase knockdowns that stabilized microtubules strongly enhanced the effects of paclitaxel treatment. Conversely, kinase knockdowns that enhanced paclitaxel-mediated cytotoxicity sensitized cells to microtubule stabilization by paclitaxel. The siRNA screen identified several genes that have not been linked previously to microtubule regulation or paclitaxel response. Gene shaving and Bayesian resampling used to classify these genes suggested three pathways of paclitaxel-induced cell death related to apoptosis and microtubule stability, apoptosis alone, or neither process. Our results offer a functional classification of the genetic basis for paclitaxel sensitivity and they support the hypothesis that stabilizing microtubules prior to therapy could enhance antitumor responses to paclitaxel treatment.
spellingShingle Ahmed, A
Wang, X
Lu, Z
Goldsmith, J
Le, X
Grandjean, G
Bartholomeusz, G
Broom, B
Bast, R
Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title_full Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title_fullStr Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title_full_unstemmed Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title_short Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel.
title_sort modulating microtubule stability enhances the cytotoxic response of cancer cells to paclitaxel
work_keys_str_mv AT ahmeda modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT wangx modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT luz modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT goldsmithj modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT lex modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT grandjeang modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT bartholomeuszg modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT broomb modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel
AT bastr modulatingmicrotubulestabilityenhancesthecytotoxicresponseofcancercellstopaclitaxel